Effects of growth hormone secretagogues on the release of adenohypophyseal hormones in young and old healthy dogs

Veterinary Journal

Volumn 172, Issue 3, 2006, Pages 515-525

  Bhatti, Sofie F M ^a   Duchateau, Luc ^a   Van Ham, Luc M L ^a   De Vliegher, Sarne P ^a   Mol, Jan A ^b   Rijnberk, Ad ^b   Kooistra, Hans S ^b  

^a GHENT UNIVERSITY   (Belgium)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Ageing; Canine; Ghrelin; Growth hormone releasing hormone; Growth hormone releasing peptide 6

Indexed keywords

ADENOHYPOPHYSIS HORMONE; CORTICOTROPIN; GHRELIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE SECRETAGOGUE; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; HYDROCORTISONE; LUTEINIZING HORMONE; PROLACTIN; THYROTROPIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOTROPIN BLOOD LEVEL; DOG; FEMALE; GROWTH HORMONE BLOOD LEVEL; HORMONE ACTION; HORMONE DETERMINATION; HORMONE RELEASE; HYDROCORTISONE BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MALE; NONHUMAN; PROLACTIN BLOOD LEVEL; THYROTROPIN BLOOD LEVEL;

ADRENOCORTICOTROPIC HORMONE; AGE FACTORS; ANIMALS; CROSS-OVER STUDIES; DOGS; FEMALE; GHRELIN; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HYDROCORTISONE; LUTEINIZING HORMONE; MALE; OLIGOPEPTIDES; PEPTIDE HORMONES; PITUITARY HORMONES, ANTERIOR; PROLACTIN; RANDOM ALLOCATION; THYROTROPIN;

CANIS FAMILIARIS;

EID: 33645230747     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2005.04.025     Document Type: Article

References (67)

1. Aloi J.A., Gertz B.J., Hartman M.L., Huhn W.C., Pezzoli S.S., Wittreich J.M., Krupa D.A., and Thorner M.O. Neuroendocrine responses to a novel growth hormone secretagogue, L-692, 429, in healthy older subjects. The Journal of Clinical Endocrinology and Metabolism 81 (1994) 4249-4257
2. Arvat E., di Vito L., Maccagno B., Broglio F., Boghen M.F., Deghenghi R., Camanni F., and Ghigo E. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. Peptides 18 (1997) 885-891
3. Arvat E., Ceda G.P., Di Vito L., Ramunni J., Gianotti L., Broglio F., Deghenghi R., and Ghigo E. Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging. Pituitary 1 (1998) 51-58
4. Arvat E., Maccario M., Di Vito L., Broglio F., Benso A., Gottero C., Papotti M., Muccioli G., Dieguez C., and Casanueva F.F. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a non-natural peptidyl GHS, and GH-releasing hormone. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 1169-1174
5. Bhatti S.F.M., De Vliegher S.P., Van Ham L., and Kooistra H.S. Effects of growth hormone-releasing peptides in healthy dogs and in dogs with pituitary-dependent hyperadrenocorticism. Molecular and Cellular Endocrinology 197 (2002) 97-103
6. Borst S.E., Millard W.J., and Lowenthal D.T. Growth hormone, exercise, and aging: the future of therapy for the frail elderly. Journal of the American Geriatrics Society 42 (1994) 528-535
7. Bowers C.Y., Chang J., Momany F.A., and Folkers K. Effect of the enkephalins and enkephalin analogs on release of pituitary hormones in vitro. In: MacIntyre G., and Szelke H. (Eds). Molecular endocrinology (1977), Elsevier, The Netherlands 287-292
8. Bowers C.Y., Momany F.A., Reynolds G.A., and Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114 (1984) 1537-1545
9. Bowers, C.Y., Newell, D., Granda-Alaya, R., Garcia, M., Barrera, C., 1992. Comparative studies on growth hormone release in younger and older men and women. In: Proceedings of the 74th Annual Meeting of the Endocrine Society, p. 172.
10. Bowers C.Y. Editorial: a new dimension on the induced release of growth hormone in obese subjects. The Journal of Clinical Endocrinology and Metabolism 76 (1993) 817-818
11. Bowers C.Y. Unnatural growth hormone-releasing peptide begets natural ghrelin. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 1464-1469
12. Broglio F., Benso A., Castiglioni C., Gottero C., Prodam F., Destefanis S., Gauna C., Van der Lely A.J., Deghengi R., Bo M., Arvat E., and Ghigo E. The endocrine response to ghrelin as function of gender in humans in young and elderly subjects. The Journal of Clinical Endocrinology and Metabolism 88 (2003) 1537-1542
13. Carpino P.A., Lefker B.A., Toler S.M., Pan L.C., Hadcock J.R., Cook E.R., DiBrino J.N., Campeta A.M., DeNinno S.L., and Chidsey-Frink K.L. Pyrazolinone-piperidine dipeptide growth hormone secretagogues. Discovery of capromorelin (GHSs). Bioorganic and Medicinal Chemistry 11 (2003) 581-590
14. Casanueva F.F., and Dieguez C. Growth hormone secretagogues: physiological role and clinical utility. Trends in Endocrinology and Metabolism 10 (1999) 30-38
15. Ceda G.P., Valenti G., Butturini U., and Hoffman A.R. Diminished pituitary responsiveness to GH-releasing factor in aging male rats. Endocrinology 118 (1986) 2109-2114
16. Cella S.G., Moiraghi V., Minuto F., Barreca A., Cocchi D., De Gennaro Colona V., Reina G., and Muller E.E. Prolonged fasting or clonidine can restore the defective growth hormone secretion in old dogs. Acta Endocrinologica 121 (1989) 177-184
17. Cella S.G., Arce V.M., Pieretti F., Locatelli V., Settembrini B.P., and Muller E.E. Combined administration of growth hormone-releasing hormone and clonidine restores defective growth hormone secretion in old dogs. Neuroendocrinology 57 (1993) 432-438
18. Cella S.G., Locatelli V., Poratelli M., De Gennaro Colonna V., Imbimbo B.P., Deghenghi R., and Muller E.E. Hexarelin, a potent GHRP analogue: interactions with GHRH and clonidine in young and aged dogs. Peptides 16 (1995) 81-86
19. Chapman I.M., Bach M.A., Van Cauter E., Farmer M., Krupa D., Taylor A.M., Schilling L.M., Cole K.Y., Skiles E.H., and Pezzoli S.S. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. The Journal of Clinical Endocrinology and Metabolism 81 (1996) 4249-4257
20. Corpas E., Harman S.M., Pineyro M.A., Roberson R., and Blackman M.R. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. The Journal of Clinical Endocrinology and Metabolism 75 (1992) 530-535
21. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T., Matsukura S., Kangawa K., and Nakazato M. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastro intestinal tracts of rats and humans. Endocrinology 141 (2000) 4255-4261
22. Daughaday W., and Rotwein P. Insulin-like growth factors I and II: peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocrine Reviews 10 (1989) 68-91
23. De Genarro Colonna V., Cella S.G., Parenti M., Locatelli V., Cocchi D., and Muller E.E. Neuroendocrine aging: its impact on somatotropic function. Neurochemistry International 25 (1994) 5-10
24. Dickson S.L., and Luckman S.M. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 138 (1997) 771-777
25. Eigenmann J.E., and Eigenmann R.Y. Radioimmunoassay of canine growth hormone. Acta Endocrinologica 98 (1981) 514-520
26. Everitt A., and Meites J. Aging and anti-aging effects of hormones. Journal of Gerontology 44 (1989) 139-147
27. Finkelstein J.W., Roffwarg H.P., Boyar R.M., Kream J., and Hellman L. Age-related change in the 24-hour spontaneous secretion of growth hormone. The Journal of Clinical Endocrinology and Metabolism 35 (1972) 665-670
28. Franchimont P., Urban-Choffray D., Lambelin P., Fontaine M.A., Frangin G., and Reginster J.Y. Effects of repetitive administration of growth hormone-releasing hormone on growth hormone secretion, insulin-like growth factor-I, and bone metabolism in postmenopausal women. Acta Endocrinologica 120 (1989) 121-128
29. Frawley L.S., and Boockfor F.R. Mammosomatotropes: presence and functions in normal and neoplastic pituitary tissue. Endocrine Reviews 12 (1991) 337-355
30. Ghigo E., Arvat E., Gianotti L., Imbimbo B.P., Lenaerts V., Deghenghi R., and Camanni F.J. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. Clinics in Endocrinology and Metabolism 78 (1994) 693-698
31. Ghigo E., Arvat E., Gianotti L., Maccario M., and Camanni F. The regulation of growth hormone secretion. In: Jenkins R.C., and Ross R.J.M. (Eds). The endocrine response to acute illness, frontiers of hormone research (1999), Karger, Basel 152-175
32. Giustina A., and Veldhuis J.D. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocrine Reviews 19 (1998) 717-797
33. Hayashida T., Murakami K., Mogi K., Nishihara M., Nakazato M., Mondal M.S., Horii Y., Kojima M., Kangawa K., and Murakami N. Ghrelin in domestic animals: distribution in stomach and its possible role. Domestic Animal Endocrinology 21 (2001) 17-24
34. Hickey G., Jacks T., Judith F., Taylor J., Schoen W.R., Krupa D., Cunningham P., Clark J., and Smith R.G. Efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretagogue, in Beagles. Endocrinology 134 (1994) 695-701
35. Jacks T., Smith R., Judith F., Schleim K., Frazier E., Chen H., Krupa D., Hora Jr. D., Nargund R., Patchett A., and Hickey G. MK-0677, a potent, novel, orally active growth hormone (GH) secretagogue: GH, insulin-like growth factor I, and other hormonal responses in beagles. Endocrinology 137 (1996) 5284-5289
36. Kelijman M. Age-related alterations of the growth-hormone/insulin-like growth factor-I axis. Journal of the American Geriatrics Society 39 (1991) 295-307
37. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
38. Korbonits M., Kaltsas G., Perry L.A., Putignano P., Grossman A.B., Besser G.M., and Trainer P.J. The GHS hexarelin stimulates the hypothalamo-pituitary-adrenal axis via AVP. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 2489-2495
39. Lamberts S.W.J. Introduction. In: Ghigo E., Boghen M., Casanueva F.F., and Dieguez C. (Eds). Growth hormone secretagogues: basic findings and clinical implications (1999), Elsevier, Amsterdam 1-5
40. Loche S., Cambiaso P., Carta D., Setzu S., Imbimbo B.P., Borrelli P., Pintor C., and Cappa M. The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects. The Journal of Clinical Endocrinology and Metabolism 80 (1995) 674-678
41. Massoud A.F., Hindmarsh P.C., and Brook D.G.D. Hexarelin-induced growth hormone, cortisol and prolactin release: a dose-response study. The Journal of Clinical Endocrinology and Metabolism 81 (1996) 4338-4341
42. Momany F.A., Bowers C.Y., Reynolds G.A., Chang D., Hong A., and Newlander K. Design, synthesis, and biological activity of peptides which release growth hormone in vitro. Endocrinology 108 (1981) 31-39
43. Muccioli G., Tschop M., Papotti M., Deghenghi R., Heiman M., and Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. European Journal of Pharmacology 440 (2002) 235-254
44. Muller E.E., Locatelli V., and Cocchi D. Neuroendocrine control of growth hormone secretion. Physiological Reviews 79 (1999) 511-607
45. Muller E.E., Rigamonti A.E., Colonna Vde G., Locatelli V., Berti F., and Cella S.G. GH-related and extra-endocrine actions of GH secretagogues in aging. Neurobiology of Aging 23 (2002) 907-919
46. Nett, T.M., Akbar, A.M., Phemister, R.D., Holst, P.A., Reichert Jr., L.E., Niswender, G.D., 1975. Levels of luteinising hormone, estradiol and progesterone in serum during the estrous cycle and pregnancy in the beagle bitch. In: Proceedings of the Society for Experimental Biology and Medicine, vol. 148, pp. 134-139.
47. Nicolas V., Prewett A., Bettica P., Mohan S., Finkelman R.D., Baylink D.J., and Farley J.R. Age-related decrease in insulin-like growth factor-I and transforming growth factor-B in femoral cortical bone from both men and women: implications for bone loss with aging. The Journal of Clinical Endocrinology and Metabolism 78 (1994) 1011-1016
48. Okkens A.C., Dieleman S.J., Bevers M.M., and Willemse A.H. Evidence for the non-involvement of the uterus in the lifespan of the corpus luteum in the cyclic dog. Veterinary Quarterly 7 (1985) 169-173
49. Patchett A.A., Nargund R.P., Tata J.R., Chen M., Barakat K.J., Johnston D.B.R., Cheng K., Chan W.W., Butler B., and Hickey G. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proceedings of the National Academy of Sciences of the United States of America 92 (1995) 7001-7005
50. Pong S.S., Chaung L.Y.P., Dean D.C., Nargund R.P., Patchett A.A., and Smith R.G. Identification of a new G-protein-linked receptor for growth hormone secretagogues. Molecular Endocrinology 10 (1996) 57-61
51. Raun K., Hansen B.S., Johansen N.L., Thogersen H., Madsen K., Ankersen M., and Andersen P.H. Ipamorelin, the first selective GHS. European Journal of Endocrinology 139 (1998) 552-561
52. Renner U., Brockmeier S., Strasburger C.J., Lange M., Schopohl J., Muller O.A., von Werder K., and Stalla G.K. Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotrope adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide. The Journal of Clinical Endocrinology and Metabolism 78 (1994) 1090-1096
53. Rigamonti A.E., Cella S.G., Marazzi N., and Muller E.E. Six-week treatment with hexarelin in young dogs: evaluation of the GH responsiveness to acute hexarelin or GHRH administration, and of the orexigenic effect of hexarelin. European Journal of Endocrinology 14 (1999) 313-320
54. Rindi G., Necchi V., Savio A., Torsello A., Zoli M., Locatelli V., Raimondo F., Cocchi D., and Solcia E. Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues. Histochemistry and Cell Biology 117 (2002) 511-519
55. Rudman D. Growth hormone, body composition and aging. Journal of the American Geriatrics Society 33 (1985) 800-807
56. Seoane L.M., Tovar S., Baldelli R., Arvat E., Ghigo E., Casanueva F.F., and Dieguez C. Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats. European Journal of Endocrinology 143 (2000) 7-9
57. Smith R.G., Van Der Ploeg L.H.T., Howard A.D., Feighner S.D., Cheng K., Hickey G.J., Wyvratt M.J., Fisher M.H., Nargund R.P., and Patchett A.A. Peptidomimetic regulation of growth hormone secretion. Endocrine Reviews 18 (1997) 621-645
58. Sonntag W.E., Steger R.W., Forman L.J., and Meites J. Decreased pulsatile release of growth hormone in old male rats. Endocrinology 107 (1980) 1875-1879
59. Svensson J., Lonn L., Jansson J.O., Murphy G., Wyss D., Krupa D., Cerchio K., Polvino W., Gertz B., Boseaus I., Sjostrom L., and Bengtsson B.A. Two-month treatment of obese subjects with the oral GH secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. The Journal of Clinical Endocrinology and Metabolism 83 (1998) 362-369
60. Takaya K., Ariyasu H., Kanamoto N., Iwakura H., Yoshimoto A., Harada M., Mori K., Komatsu Y., Usui T., and Shimatsu A. Ghrelin strongly stimulates growth hormone release in humans. The Journal of Clinical Endocrinology and Metabolism 85 (2000) 4908-4911
61. Thomas G.B., Fairhall K.M., and Robinson I.C.A.F. Activation of the hypothalamo-pituitary-adrenal axis by the Growth-Hormone (GH) Secretagogue, GH-Releasing Peptide-6, in rats. Endocrinology 138 (1997) 1585-1591
62. Tomasetto C., Wendling C., Rio M.C., and Poitras P. Identification of cDNA encoding motilin related peptide/ghrelin precursor from dog fundus. Peptides 22 (2001) 2055-2059
63. Van Eekelen J.A., Oitzl M.S., and De Kloet E.R. Adrenocortical hyporesponsiveness and glucocorticoid feedback resistance in old male brown Norway rats. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 50 (1995) 83-89
64. Walker R.F., Codd E.E., Barone F.C., Nelson A.H., Goodwin T., and Campbell S.A. Oral activity of the growth hormone releasing peptide His-d-Trp-Ala-trp-d-phe-Lys-NH2 in rats, dogs, and monkeys. Life Science 47 (1990) 29-36
65. Walker R.F., Yang S.-W., and Bercu B.B. Robust growth hormone (GH) secretion in aged female rats co-administered GH-releasing hexapeptide (GHRP-6) and GH-releasing hormone (GHRH). Life Science 49 (1991) 1499-1504
66. Wilshire G.B., Loughlin J.S., Brown J.R., Adel T.E., and Santoro N. Diminished function of the somatotropic axis in older reproductive-aged women. The Journal of Clinical Endocrinology and Metabolism 80 (1995) 608-613
67. Zadik Z., Chalew S.A., Mc Carter Jr. R.J., Meistas M., and Kowarski A.A. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. The Journal of Clinical Endocrinology and Metabolism 60 (1985) 513-516